Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program (EAP) for developers of gene-edited therapies that allow for the ...
- Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity - Peer-reviewed data demonstrates the sensitivity of ...
Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization Broken String Biosciences (“Broken String”), ...
Resulting technology, called SafeGuide, will enable faster, more cost-effective development of gene edited therapies like CRISPR BOSTON & CHICAGO & CAMBRIDGE, England, July 10, 2025--(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results